Supplementary Figure S6. from ICEC0942, an Orally Bioavailable Selective Inhibitor of CDK7 for Cancer Treatment

Abstract

<p>Pharmacokinetic determination of ICEC0942 plasma and tumor concentrations at different doses and over time.</p>